13-O-Decladinosylazithromycin (as per EP) ; (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-Ethyl-3,4,10,13-tetrahydroxy-3,5,6,8,10,12,14-heptamethyl-11-[[3,4,6-trideoxy-3-dimethylamino-Beta-D-xylo-hexopyranosyl]oxy]-1-oxa-6-azacyclopentadecan-15-one (as per USP)
13-O-Decladinosylazithromycin (as per EP) ; (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-Ethyl-3,4,10,13-tetrahydroxy-3,5,6,8,10,12,14-heptamethyl-11-[[3,4,6-trideoxy-3-dimethylamino-Beta-D-xylo-hexopyranosyl]oxy]-1-oxa-6-azacyclopentadecan-15-one (as per USP)
+917744015207
info@medglowpharma.com | sales@medglowpharma.com
H.N. 1-1-111,Swapnaganda, Paras Nagar ,Nanded Maharastra, India -431602
Monday to Saturday 9am to 7pm
Services
API intermidates
Custom synthesis
API impurities
Working standards
Portfolio
Medglow Pharma Private Limited is a newly incorporated private company, registered under the Registrar of Companies (RoC), RoC-Delhi. It was registered with an authorized and paid-up capital of ₹1,00,000. The company falls under the class of Non-government companies. It was registered in 2025.
